🌅 Pre-Market Pulse

S&P Futures 7,491.50 ▲ +19.25 (+0.26%)	Nasdaq Futures 29,556.25 ▲ +29.00 (+0.10%)	Dow Futures 50,149.00 ▲ +251.00 (+0.50%)
10Y Treasury 4.48% ▲ +0.02%	US Dollar 98.53 ▲ +0.03 (+0.03%)	Bitcoin $79,474 ▲ +$185 (+0.23%)

Good morning! Thursday is shaping up to be one of those mornings where there is genuinely a lot to process before the opening bell even rings. From a landmark Trump-Xi summit lifting sentiment across the board to a potentially historic crypto bill heading into committee, the news flow is thick and meaningful. Pull up a chair and let's get into it.

👀 What to Watch Today

The headline event for today's session is the Senate Banking Committee review of new cryptocurrency legislation. This is a meaningful step forward for an industry that has been waiting years for regulatory clarity, and the outcome could move crypto-adjacent names in real time. Keep an eye on Bitcoin, currently sitting at $79,474 in pre-market, and watch how stocks with crypto exposure trade as headlines cross.

On the IPO front, Cerebras Systems is set to begin trading today in what is being called the biggest IPO of the year. Artificial intelligence infrastructure is the backbone of the Cerebras story, and in a market still hungry for AI plays, this debut will be closely watched for both price action and what it signals about appetite for new listings.

AstraZeneca (AZN) is also in focus after announcing positive late-stage trial results for its drug Imfinzi in bladder cancer treatment. Biotech and pharma traders will want to watch AZN carefully today, as strong survival data from oncology trials tends to move the stock and ripple across the broader healthcare sector.

Shocker: What's being created inside Elon Musk's secret lab? [ad]

🌏 Overnight Recap

Overnight, global markets took their cues from diplomatic optimism surrounding the Trump-Xi summit, with futures across all three major US indexes pointing higher heading into Thursday's open. S&P 500 futures are up 0.26%, Dow futures are leading the charge at plus 0.50%, and Nasdaq futures are modestly positive at plus 0.10%. The tone is constructive without being euphoric.

Out of Asia, Foxconn (HNHAF) delivered a strong earnings beat, reporting an 18.5% jump in first-quarter profit that topped analyst expectations. That is a meaningful data point for anyone watching the electronics supply chain and the broader AI hardware buildout, given Foxconn's central role in manufacturing for the world's biggest tech companies.

In Europe, Burberry (BURBY) offered a rare bright spot for luxury retail, reporting a 5% sales increase as its turnaround plan continues to gain traction despite ongoing geopolitical headwinds. Meanwhile, the UK's Competition and Markets Authority kicked off a formal antitrust investigation into Microsoft's (MSFT) business software dominance, a development that adds regulatory overhang to one of the market's most widely held names.

Most important tech breakthrough since 1958?? [ad]

📊 Pre-Market Movers

AstraZeneca (AZN) is among the more notable pre-market movers this morning after announcing that Imfinzi, combined with a targeted therapy used before surgery, delivered a statistically significant improvement in survival rates for muscle-invasive bladder cancer patients. Oncology data of this quality tends to generate fast-moving price action, and AZN deserves a spot on your screen today.

Foxconn's parent entities (HNHAF, HNHPF) are drawing attention after the overnight earnings beat. An 18.5% profit increase for the world's largest contract electronics manufacturer is not a small number, and it speaks to continued strength in device and server demand, particularly as AI infrastructure spending accelerates globally.

Honda (HMC) is moving in the opposite direction after reporting its first annual loss in nearly 70 years. A combination of US tariff pressure and a more than 9 billion dollar charge tied to restructuring its EV division hit the automaker hard. HMC is worth watching as a bellwether for how legacy automakers are absorbing the cost of the electric vehicle transition in a tariff-heavy environment.

How to profit from the "Warsh Shock" [ad]

🔍 Today's Watchlist

1. MSFT: UK antitrust probe into business software could pressure shares and invite scrutiny of licensing practices
2. AZN: Imfinzi bladder cancer trial results are positive, watch for analyst upgrades and sector rotation into pharma
3. Cerebras Systems IPO debut: the year's biggest listing hits the tape today, a real-time read on AI investor appetite
4. 10-Year Treasury at 4.48%: yields ticking higher as risk appetite improves, watch for any bond market pushback
5. Crypto legislation: Senate Banking Committee review today could be a catalyst for Bitcoin and digital asset equities

🎯 The Morning Playbook

Today is a session with genuine multiple catalysts running simultaneously, which means discipline matters more than usual. The Cerebras IPO is the narrative headline, but it is the crypto bill in the Senate Banking Committee that could have longer-lasting market implications. Regulatory clarity for digital assets would be a structural positive for the space, not just a one-day trade.

On the macro side, Treasury yields are nudging higher with the 10-year at 4.48%, which is worth monitoring as the session progresses. A sustained move higher in yields could cap gains in rate-sensitive growth names even as futures point to a positive open. The Dow's outperformance in futures, up half a percent, suggests value and cyclicals may lead today.

The broader setup is constructive. Diplomatic progress on the US-China front, a strong IPO calendar, and meaningful biotech data give the bulls something to work with. Stay focused on what the data is actually telling you, and do not let the noise drown out the signal.

Bigger than xAI, SpaceX, PayPal and Tesla… COMBINED? [ad]